GEODE CAPITAL MANAGEMENT, LLC
Position in IKT — Inhibikase Therapeutics, Inc.
CIK 1214717
BOSTON, MA
Position in IKT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,292,471
+$1,646,559 QoQ
Shares Held
2,607,129
+20.1% QoQ
Ownership
1.87%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 105 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IKT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. IKT ranks #231 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in IKT
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,292,471 | 2,607,129 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $3,645,912 | 2,170,186 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,312,889 | 1,128,239 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,802,369 | 1,112,574 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $2,080,064 | 1,066,700 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $711,224 | 324,760 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,049,352 | 322,878 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $65,084 | 50,065 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $45,169 | 37,330 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $61,974 | 28,692 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $36,438 | 28,692 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $39,881 | 28,692 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $53,572 | 14,840 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $58,593 | 89,048 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $44,524 | 89,048 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $81,195 | 89,226 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $66,294 | 89,226 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $124,629 | 84,209 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $116,318 | 79,128 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $49,082 | 25,833 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||